A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for the treatment of a chronic lung condition, the drugmaker said on Friday.

AstraZeneca PLC closed 18.54% short of its 52-week high of £133.88, which the company reached on September 3rd.

AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...

The company plans to invest billions in a new drug manufacturing hub in Virginia, dedicated to chronic disease treatments, alongside additional facilities in California, Indiana, Maryland, ...

British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...

Xelix, a leading agentic AI software company in the Accounts Payable (AP) space, today announced a $160 million Series B ...

AstraZeneca on Wednesday said that its experimental therapy anselamimab did not meet the main goal of a late-stage study for ...

Mamdani campaign spokesman Andrew Epstein said Mamdani is a Mets fan but has nothing to do with knockoff caps or its sellers.

AstraZeneca PLC closed 19.32% short of its 52-week high of £133.88, which the company achieved on September 3rd.

Celebrate the splendor of sundown with these beautiful sunset quotes for Instagram and any other occasion. Find short sunset quotes and sunset quotes on life.

AstraZeneca PLC (NASDAQ:AZN) is one of the 10 best defensive stocks to buy in a volatile market. On July 4, the company entered into a multi-year agreement with Modella AI.